Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human immunodeficiency virus type 1 reverse transcriptase and protease mutation search engine for queries

R W Shafer1, D R Jung, B J Betts

  • 1Division of Infectious Diseases, School of Medicine, Stanford University, Stanford, California 94305, USA. rshafer@cmgm.stanford.edu

Nature Medicine
|November 4, 2000
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prediction of response to antiretroviral therapy by human experts and by the EuResist data-driven expert system (the EVE study).

HIV medicine·2010
Same author

A highly divergent picornavirus in a marine mammal.

Journal of virology·2007
Same author

The mitochondrial pharmacogenomics of haplogroup T: MTND2*LHON4917G and antiretroviral therapy-associated peripheral neuropathy.

The pharmacogenomics journal·2007
Same author

Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases·2006
Same author

Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay.

Journal of virology·2004
Same author

An update on the diagnosis and treatment of HIV, 1998.

Drugs of today (Barcelona, Spain : 1998)·2004
Same journal

Generalizable AI predicts immunotherapy outcomes across cancers and treatments.

Nature medicine·2026
Same journal

Immune aging biomarkers for clinical trials.

Nature medicine·2026
Same journal

Lassa fever countermeasures gather pace.

Nature medicine·2026
Same journal

Why high scores do not mean application readiness for health AI.

Nature medicine·2026
Same journal

Polypill for heart failure with reduced ejection fraction: the POLY-HF randomized trial.

Nature medicine·2026
Same journal

Biological aging might help to explain the rising risk of early-onset cancer.

Nature medicine·2026
See all related articles